An Open-Label Trial of Pregabalin in Patients With Fibromyalgia

Completed · Phase 3

Conditions studied: Fibromyalgia

In brief

The main purpose of this protocol is to evaluate the long-term safety of pregabalin in patients who participated in the previous fibromyalgia Study A0081056 and who wish to receive open-label pregabalin therapy.

Key facts

Study ID

NCT00151528

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

428

Starts

2005-01-01

Expected to finish

2006-06-01

Last updated by the study team

2021-01-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients must have met the inclusion criteria for the preceding fibromyalgia Protocol A0081056
• Must have received pregabalin/placebo under double-blind conditions.

You may not qualify if…

• Patients may not participate in the study if they experienced a serious adverse event during the previous fibromyalgia Study A0081056 which was determined to be related to the study medication by the investigator or the sponsor.

Where it is running

• Pfizer Investigational Site — Birmingham, Alabama, United States
• Pfizer Investigational Site — Huntsville, Alabama, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Scottsdale, Arizona, United States
• Pfizer Investigational Site — Hot Springs, Arkansas, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Beverly Hills, California, United States
• Pfizer Investigational Site — Los Alamitos, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — Northridge, California, United States
• Pfizer Investigational Site — Pismo Beach, California, United States
• Pfizer Investigational Site — Redondo Beach, California, United States
• Pfizer Investigational Site — Riverside, California, United States
• Pfizer Investigational Site — Walnut Creek, California, United States
• Pfizer Investigational Site — Whittier, California, United States
• Pfizer Investigational Site — Danbury, Connecticut, United States
• Pfizer Investigational Site — New Milford, Connecticut, United States
• Pfizer Investigational Site — Stratford, Connecticut, United States
• Pfizer Investigational Site — Clearwater, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Palm Beach Gardens, Florida, United States
• Pfizer Investigational Site — Seminole, Florida, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.